Clear Harbor Asset Management, LLC Amryt Pharma PLC Transaction History

Clear Harbor Asset Management, LLC

  • $1.22 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 20, 2023
SELL
$6.68 - $7.58 $90,667 - $102,883
-13,573 Reduced 15.35%
74,843 $0
Q2 2022

Jul 20, 2022
BUY
$6.85 - $8.87 $9,076 - $11,752
1,325 Added 1.52%
88,416 $618,000
Q1 2022

May 10, 2022
BUY
$6.3 - $10.86 $328,860 - $566,892
52,200 Added 149.61%
87,091 $720,000
Q4 2021

Jan 21, 2022
BUY
$9.44 - $12.24 $329,371 - $427,065
34,891 New
34,891 $377,000

Others Institutions Holding AMYT

# of Institutions
5
Shares Held
142K
Call Options Held
0
Put Options Held
0
View Full List

About Amryt Pharma plc

AMYT Quotes by TradingView
  • Ticker AMYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 64,177,000
  • Description
  • Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...
More about AMYT
Track This Portfolio

Track Clear Harbor Asset Management, LLC Portfolio

Follow Clear Harbor Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Harbor Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Harbor Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email